Cardiovascular Protection With SGLT2 Inhibitors and Mineralocorticoid Receptor Antagonists in Patients With Chronic Kidney Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Hypertension
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Cardiovascular Protection With Sodium-Glucose Cotransporter-2 Inhibitors and Mineralocorticoid Receptor Antagonists in Chronic Kidney Disease: A Milestone Achieved
Hypertension 2021 Mar 29;[EPub Ahead of Print], P Sarafidis, CE Papadopoulos, V Kamperidis, G Giannakoulas, M DoumasFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.